Testing version — LOERadar is in active testing. Features and data may change.
ATEBRIOZ (ZILURGISERTIB FUMARATE) | LOERadar
Not in the current Orange Book — This application is not listed in FDA's current Orange Book data files (no listed patents or exclusivities). Product and approval data shown are from FDA's Drugs@FDA database.
ATEBRIOZ
NDANot in Orange Book
ZILURGISERTIB FUMARATE | N221198 | MIRUM
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — EQ 25MG BASE
▴
TABLET;ORAL | Approved: Sep. 25, 2026
Patents (3) · 2 use codes
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
10710980Newly listed — daily FDA feed, not yet in monthly Orange Book edition
Jul 18, 2037
—
Yes
Yes
—
—
10947218Newly listed — daily FDA feed, not yet in monthly Orange Book edition
Jul 18, 2037
—
—
—
—
12466808Newly listed — daily FDA feed, not yet in monthly Orange Book edition